Michael Postow, MD, is Chief of the Melanoma Service and Co-Director of the Melanoma Disease Management Team at Memorial Sloan Kettering Cancer Center (MSK). A medical oncologist specializing in melanoma, Dr. Postow’s clinical and research work focuses on developing and evaluating new treatments for the disease, including immunotherapy, targeted therapy, and clinical trials.
Segment
Listen
What an mRNA melanoma vaccine may mean for cancer treatment
Moderna and Merck say an mRNA vaccine reduced melanoma recurrence in a clinical trial. Could this usher in a new era of cancer treatment?